A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis

Research output: Contribution to journalArticle

Bibtex

@article{c5d2e3595e354c36abcbe2a6c41c61e9,
title = "A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis",
abstract = "Disease recurrence in surgically treated lung adenocarcinoma (AC) remains high. New approaches for risk stratification beyond tumor stage are needed. Gene expression-based AC subtypes such as the Cancer Genome Atlas Network (TCGA) terminal-respiratory unit (TRU), proximal-inflammatory (PI) and proximal-proliferative (PP) subtypes have been associated with prognosis, but show methodological limitations for robust clinical use. We aimed to derive a platform independent single sample predictor (SSP) for molecular subtype assignment and risk stratification that could function in a clinical setting. Two-class (TRU/nonTRU=SSP2) and three-class (TRU/PP/PI=SSP3) SSPs using the AIMS algorithm were trained in 1655 ACs (n = 9659 genes) from public repositories vs TCGA centroid subtypes. Validation and survival analysis were performed in 977 patients using overall survival (OS) and distant metastasis-free survival (DMFS) as endpoints. In the validation cohort, SSP2 and SSP3 showed accuracies of 0.85 and 0.81, respectively. SSPs captured relevant biology previously associated with the TCGA subtypes and were associated with prognosis. In survival analysis, OS and DMFS for cases discordantly classified between TCGA and SSP2 favored the SSP2 classification. In resected Stage I patients, SSP2 identified TRU-cases with better OS (hazard ratio [HR] = 0.30; 95% confidence interval [CI] = 0.18-0.49) and DMFS (TRU HR = 0.52; 95% CI = 0.33-0.83) independent of age, Stage IA/IB and gender. SSP2 was transformed into a NanoString nCounter assay and tested in 44 Stage I patients using RNA from formalin-fixed tissue, providing prognostic stratification (relapse-free interval, HR = 3.2; 95% CI = 1.2-8.8). In conclusion, gene expression-based SSPs can provide molecular subtype and independent prognostic information in early-stage lung ACs. SSPs may overcome critical limitations in the applicability of gene signatures in lung cancer.",
keywords = "gene expression, lung adenocarcinoma, molecular subtypes, prognosis, single sample predictor",
author = "Helena Liljedahl and Anna Karlsson and Oskarsdottir, {Gudrun N.} and Annette Salomonsson and Hans Brunnstr{\"o}m and Gigja Erlingsdottir and Mats J{\"o}nsson and Sofi Isaksson and Elsa Arbajian and Cristian Ortiz-Villal{\'o}n and Aziz Hussein and Bengt Bergman and Anders Vikstr{\"o}m and Nastaran Monsef and Eva Branden and Hirsh Koyi and {de Petris}, Luigi and Annika Patthey and Behndig, {Annelie F.} and Mikael Johansson and Maria Planck and Johan Staaf",
year = "2021",
month = jan,
day = "1",
doi = "10.1002/ijc.33242",
language = "English",
volume = "148",
pages = "238--251",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "John Wiley and Sons",
number = "1",

}